Intraday system for the future of SP500 and NQ, made by our Genetic Builder with the improvements of the new 2022 methodology.
These versions of intraday systems support contract pyramiding with excellent results.
It is recommended to operate together, with the pyramiding version, and the non-pyramidizing version of the ES.
Trades the future of Nasdaq and SP500
NQ / ES
Intraday system for the Nasdaq future, made by our Genetic Builder.
Intraday system for Nasdaq futures, made by our Genetic Builder. A maximum of 4 contracts (Emini or micro) per buyer is allowed to protect liquidity.
Intraday system for the Nasdaq future, made by our Genetic Builder. A maximum of 4 contracts (Emini or micro) per buyer is allowed to protect liquidity.
Hypothetical performance results have many inherent limitations, some of which are described below.
No representation is being made that any account will or may make profits or losses similar to those shown. In fact, there are often large differences between hypothetical performance results and the actual results subsequently achieved by any particular trading strategy.
One of the limitations of hypothetical performance results is that they are generally prepared with the benefit of hindsight. In addition, counterfactual trading does not involve financial risk, and no counterfactual trading record can fully explain the impact of financial risk on actual trading.
For example, the ability to withstand losses or stick to a particular trading strategy despite trading losses are important points that can also adversely affect actual trading results. There are numerous other factors related to the markets in general or the implementation of any specific trading strategy that cannot be fully considered in the preparation of hypothetical performance results and all of which may adversely affect actual trading results.